British Liver Trust join 60+ charities in calling on the Prime Minister to take urgent action to curb the cancer crisis

March 22, 2023

The British Liver Trust have joined over 60 charities and 80,000 signatories in calling on the Prime Minister Rishi Sunak to take dedicated action to tackle the cancer emergency.

The petition was launched in response to the promised 10-year cancer plan being scrapped by the Government in favour of a five-year Major Conditions Strategy which covers a wide range of complex conditions diluting focus on cancer services.

The British Liver Trust, along with the five other health charities form the Less Survivable Cancer Taskforce (LSCT) represent the six less survivable cancers, liver, lung, brain, oesophageal, pancreatic and stomach. Combinedn these cancers make up nearly half of all common cancer deaths in the UK.

British Liver Trust Chief Executive, Pamela Healy OBE said: “We are proud to join One Cancer Voice in calling on the Prime Minister to take urgent action to turn the tide on the cancer crisis and improve prevention, early detection, outcomes and care.

“Liver cancer is the fastest rising cause of cancer death in the UK with a five-year survival rate of just 13%. We need dedicated action now more than ever to close the deadly cancer gap and improve outcomes for liver cancer patients and the less survivable cancers.”

Representing the British Liver Trust, Paul McGlinchey joined campaigners and Chair of the Health and Social Care Committee, Steve Brine MP, at Westminster to send a clear message to Downing Street that dedicated action is needed to help improve cancer outcomes and save lives.

More news

Potential for hundreds more liver transplants after NICE recommends new life-saving liver procedure for NHS use

Potential for hundreds more liver transplants after NICE recommends new life-saving liver procedure for NHS use

The British Liver Trust welcomes the news that hundreds more liver transplants could be carried out after a new procedure that supplies a donor liver with oxygen before removal was approved by NICE for use in the NHS.   In-situ ...
New hope for people living with MASH as two treatments receive MHRA approval

New hope for people living with MASH as two treatments receive MHRA approval

People living with metabolic dysfunction-associated steatohepatitis (MASH) have received encouraging news, with the UK medicines regulator approving two treatments for the condition within the past month. The Medicines and Healthcare ...
New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease

New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease

A major new Lancet Gastroenterology & Hepatology Commission, published today, has shone a spotlight on the crucial role that primary care can play in preventing, detecting and managing liver disease. We were proud to contribute to ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.